Position in OGN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$659,343
+$98,020 QoQ
Shares Held
48,696
+162.5% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#173
of 626 holders
Holding Since
Jun 2021
2 quarters on record
Voting authority
Sole 31%
Shared 0%
None 69%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Lido Advisors, LLC holds $485,897,181 across 15 Drug Manufacturers - General names. OGN ranks #14 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
114,252 | $137,037,286 | |
| 2 | ABBV |
AbbVie Inc.
|
459,683 | $115,674,628 | |
| 3 | JNJ |
Johnson & Johnson
|
392,685 | $99,730,207 | |
| 4 | MRK |
Merck & Co., Inc.
|
378,859 | $48,683,381 | |
| 5 | AMGN |
Amgen Inc
|
77,970 | $28,234,494 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
153,825 | $19,434,249 | |
| 7 | PFE |
Pfizer Inc
|
421,273 | $10,144,251 | |
| 8 | AZN |
Astrazeneca PLC
|
41,103 | $7,793,949 |
All Filings in OGN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $659,343 | 48,696 | Shares | Sole | 2026-08-07 | |
| 2021-06-30 | $561,323 | 18,550 | Shares | Sole | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||